Autoantibodies to IA-2 and GAD65 in Patients with Type 2 Diabetes Mellitus of Varied Duration: Prevalence and Correlation with Clinical Features

Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies

Charles F. Verge, Roberto Gianani, Eiji Kawasaki et al. · Diabetes · 1996 · 794 citations

Life Sciences, Endocrinology, Immunology +17

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

Robert C. Turner, Irene Stratton, V. Horton et al. · The Lancet · 1997 · 791 citations

Life Sciences, Endocrinology, Molecular Biology +17

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

Anne Clark, Christopher A. Wells, I Buley et al. · PubMed · 1988 · 519 citations

Medicine, Endocrinology, Pathology +17

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

Annelie Carlsson, H Li, Bo Isomaa et al. · Diabetes · 1999 · 506 citations

Medicine, Endocrinology, Internal Medicine +16

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

Charles F. Verge, David Stenger, Ezio Bonifacio et al. · Diabetes · 1998 · 425 citations

Life Sciences, Endocrinology, Immunology +17